Banner

Welcome to

Hematology, Oncology, and Cellular Therapy

Share

OUR EXPERTISE

Contact Hematology, Oncology, and Cellular Therapy at CHAM


Donate to Help Fight Childhood Cancers and Blood Disorders

Badge-ChildrensHospitals-Cancer-Year.pngAddressing the physical, medical and emotional needs of children with cancer and blood disorders requires a complex mix of highly specialized care, state-of-the-art technology, child-centered facilities and a passionate, skilled team of physicians and support staff.

Our division has a solid and long-standing reputation for excellence in treating pediatric, adolescent and young adult patients with cancer and blood disorders.  CHAM has played a pioneering role, as the first and only hospital in the New York metropolitan area to offer virtually everything needed for the care and treatment of childhood cancers all under one roof. This fact continues to attract patients from across the country and the globe to us for the most cutting-edge, comprehensive treatment options.

 

OUR TEAM

David Loeb, MD, PhD

Our team is committed to providing cutting-edge therapies, including early phase clinical trials, to the children and young adults of our community and throughout the region. We provide the highest quality care possible, centered on the family and coupled with comprehensive psychosocial support.

 

David Loeb, MD, PhD

Chief, Division of Pediatric Hematology, Oncology, Marrow and Blood Cell Transplantation
Director, Sarcoma Program
Professor, Pediatrics and Developmental and Molecular Biology

Education & Training

CHAM_HemOnc_New

Comprehensive and Accreditation Council for Graduate Medical Education-accredited, this three-year fellowship training program clinically and intellectually challenges the next generation of pediatric hematology and oncology clinician-scientists. Receiving superior training from seasoned faculty supported by a National Institutes of Health (NIH)-funded Hematology Program in oncological and hematological clinical care, fellows conduct clinical, translational, and basic science research. CHAM allows fellows the opportunity to learn at a dynamic children’s hospital with a well-respected medical school and a broad-based patient population.

Learn About Our Fellowship Program

RESEARCH

GettyImages-713768491-316x210.jpg

The research mission of our team is to discover and then rapidly introduce into clinical use novel approaches to curing childhood cancer and blood disorders. Our multi-disciplinary approach to research allows our physician-scientists to apply cutting-edge advances in immunology, cancer biology, genetics, and pharmacology to most effectively treat our patients. For example:

  • David Loeb, MD, PhD, directs a translational research laboratory focused on understanding bone tumors, metastatic spread, and new approaches to management.
  • Deepa Manwani, MD, internationally recognized for her expertise in pediatric hematologic disorders, runs an NIH-funded study of new treatment for sickle cell disease.
  • Allison Martin, MD, is an NIH-funded investigator who studies novel immunotherapeutic approaches for children with brain tumors.
  • Daniel Weiser, MD, runs a translational research laboratory performing state-of-the-art biomarker testing in osteosarcoma and neuroblastoma.

In addition to offering clinical studies based on discoveries in the research laboratories at CHAM and Albert Einstein College of Medicine, our physicians are committed to providing patients and families with the most current and innovative clinical trials through internationally-recognized consortia including the Children’s Oncology Group (COG), Dana-Farber Cancer Institute (DFCI), and National Pediatric Cancer Foundation.

 

FIND A CLINICAL TRIAL